Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody

Journal of Clinical Microbiology

Volumn 39, Issue 7, 2001, Pages 2518-2524

  Saville, R D ^a   Constantine, N T ^a   Cleghorn, F R ^a   Jack, N ^a   Bartholomew, C ^a   Edwards, J ^a   Gomez, P ^a   Blattner, W A ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ANTIBODY SCREENING; ANTIGEN DETECTION; ARTICLE; COST CONTROL; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES;

EID: 0034957841     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.7.2518-2524.2001     Document Type: Article

References (27)

1. VIDAS immunoassay system
2. Supplemental tests for HIV-1 infection
3. Sensitivity of HIV antibody assays as determined by seroconversion panels
4. Diagnostic challenges for rapid human immunodeficiency virus assays. Performance using HIV-1 group O, HIV-1 group M, and HIV-2 samples
5. HIV antibody testing
6. Tests to detect HIV antigen
7. Combined screening tests for anti-HIV antibodies and p24 antigen
8. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
9. Global goals of today's blood banks
10. Changing the natural history, of HIV disease
11. Blood and blood product safety
12. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection
13. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay
14. Evaluation of a new screening assay kit for the combined detection of HIV p24 antigen and antibody-comparison of the performance of the new kit and HIV antibody assay kits
15. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes
16. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States
17. Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing
18. New lineal immunoenzymatic assay for simultaneous detection of p24 antigen and HIV antibodies
19. Evaluation of combined tests to human immunodeficiency viruses type 1 and 2 antibodies screening
20. Evaluation of organon teknika vironostika HIV Uni-Form II Ag/Ab on the ortho summit processor
21. A prototype fully automated chemiluminescent screening assay for the combined detection of HIV antigens and antibodies
22. Evaluation of organon teknika's new vironostika HIV Uni-Form II Ag/Ab assay
23. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 Ag detection: A new generation vironostika HIV Uni-Form II
24. Improved performance of seroconversion with a 4th generation HIV antigen/antibody assay
25. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays
26. Early diagnosis of primary HIV infections: Using a combined screening test (p24 antigen and anti-HIV antibodies)